echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > The World Health Organization approves the emergency use list application for Johnson's single-dose new coronary pneumonia vaccine

    The World Health Organization approves the emergency use list application for Johnson's single-dose new coronary pneumonia vaccine

    • Last Update: 2021-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Johnson & Johnson announced on March 13 that the World Health Organization (WHO) has approved the emergency use list (EUL) application for a single-dose new coronary pneumonia vaccine developed by Johnson & Johnson's Janssen Pharmaceutical Company (hereinafter referred to as "Janssen").


    Data from the Phase 3 ENSEMBLE study showed that Johnson & Johnson's new coronary pneumonia vaccine was well tolerated, and the incidence of symptomatic new coronary pneumonia after vaccination was 67% lower than that of subjects in the placebo group.


    The EUL procedure simplifies the process by which governments and United Nations procurement agencies evaluate new or unapproved products for use during public health emergencies.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.